Slide 1: Q4 and Full Year 2012 Results
Q4 and Full Year 2012 Results March 6, 2013
Slide 2: Profit & Loss: Key Figures (in million Euro)
Profit & Loss: Key Figures (in million Euro) Q4'11 Q4'12 ∆% FY'11 FY'12 ∆% (excl. X-rate) (excl. X-rate) Sales 805 812 0.9% (-1.3%) 3,023 3,091 2.2%(-1.6%) Gross Profit* 218 227 4.1% 846 870 2.8% as a % of sales 27.1% 28.0% 28.0% 28.1% SG&A* -149 -142 -4.7% -574 -573 -0.2% SG&A as % of sales 18.5% 1
Slide 3: Net Financial Debt (in million Euro)
Net Financial Debt (in million Euro) 661 569 500 445 434 391 398 313 339 267 291 306 295 291 161 189 09 09 09 09 10 10 10 11 11 11 11 12 12 12 12 0 21 1' 2' 3' 4' 1' 3' 4' 1' 2' 3' 4' 1' 2' 3' 4' Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q 3
Slide 4: Working Capital: Key Figures (in million Euro/days)
Working Capital: Key Figures (in million Euro/days) 800 Inventories 800 Trade Receivables* 800 Trade Payables 700 717719 711 700 700 688 688 691 600 627 639 635 600 600 591 585 583 577 543 539 500 514 500 521532 527 500 483 496 487482 498 473471482 476 469 467 438 452 400 400 400 300 300 300 119 123
Slide 5: Main Group Drivers behind Key Figures
Main Group Drivers behind Key Figures Q4 2012 • Both Agfa Graphics and Agfa HealthCare business groups contributed to the growth • In the emerging markets, the Group achieved double digit revenue growth • The gross profit margin improved thanks to efficiency improvements, volume increases and price
Slide 6: Profit & Loss: Key Figures (in million Euro)
Profit & Loss: Key Figures (in million Euro) Q4 '11 Q4 '12 ∆% FY'11 FY'12 ∆% Recurring EBIT* 43 57 32.6% 129 139 7.8% Restructuring and non-recurring -55 -20 -63.6% -93 -43 -53.8% Operating result -12 37 408.3% 36 96 166.7% Non-operating result -19 -25 -84 -107 Profit before taxes -31 12 -48 -11 Tax
Slide 7: Graphics
Graphics AGFA <>
Slide 8: Graphics: Key Figures (in million Euro)
Graphics: Key Figures (in million Euro) Q4'11 Q4'12 ∆% FY'11 FY'12 ∆% (excl. curr.) (excl. curr. ) Sales 418 421 0.7%(-1.8%) 1,596 1,652 3.5%(-1.0%) Gross Profit* 97 100 3.1% 402 408 1.5% as a % of sales 23.2% 23.8% 25.2% 24.7% SG&A* -78 -75 -3.8% -313 -312 -0.3% as % of sales 18.7% 17.8% 19.6% 18.9
Slide 9: Graphics: Main Drivers behind Key Figures
Graphics: Main Drivers behind Key Figures Q4 2012 • In CtP, volumes slightly increased versus Q4 2011 • In CtF, revenue remained stable due to normalization of film volumes • In Industrial Inkjet, the impact of the adverse economic conditions was more severe than in the earliest quarters of the year
Slide 10: Graphics: YTD Sales per Business Segment
Graphics: YTD Sales per Business Segment FY 2012 100% = 1,652 million Euro Inkjet, Software, Service 17% Analog Prepress 19% Digital Prepress 64% 10
Slide 11: HealthCare
HealthCare AGFA <>
Slide 12: HealthCare: Key Figures (in million Euro)
HealthCare: Key Figures (in million Euro) Q4'11 Q4'12 ∆% FY'11 FY'12 ∆% (excl. curr.) (excl. curr. ) Sales 333 337 1.2%(-0.8%) 1,177 1,212 3.0%(-0.3%) Gross Profit* 116 120 3.4% 410 433 5.6% as a % of sales 34.8% 35.6% 34.8% 35.7% SG&A* -64 -61 -4.7% -237 -236 -0.4% as % of sales 19.2% 18.1% 20.1% 1
Slide 13: HealthCare: Main Drivers behind Key Figures
HealthCare: Main Drivers behind Key Figures Q4 2012 • In the Imaging segment, the digital radiography business continued to grow • In the IT segment, sales were lower than in the exceptionally strong Q4 2011 • Agfa HealthCare achieved strong double-digit revenue growth in the emerging markets, where
Slide 14: HealthCare: YTD Sales per Business Segment
HealthCare: YTD Sales per Business Segment FY 2012 100% = 1,212 million Euro Hardcopy 30% Classic Radiology 12% CR/Modalities 19% Imaging IT* HIS/CIS 27% 12% HealthCare IT = 39% * Includes Radiology and Cardiology IT 14
Slide 15: Specialty Products
Specialty Products AGFA <>
Slide 16: Specialty Products: Key Figures (in million Euro)
Specialty Products: Key Figures (in million Euro) Q4'11 Q4'12 ∆% FY'11 FY'12 ∆% (excl. curr.) (excl. curr. ) Sales 54 54 0.0% (0.1%) 250 227 -9.2%(-10.8%) Gross Profit* 5 7 40.0% 34 29 -14.7% as a % of sales 9.3% 13.0% 13.6% 12.8% SG&A* -6 -7 16.7% -23 -25 8.7% as % of sales 11.1% 13.0% 9.2% 11.0% R
Slide 17: Specialty Products: Main Drivers behind Key Figures
Specialty Products: Main Drivers behind Key Figures Q4 2012 • Contrary to previous quarters, revenue remained stable, with good performances of Orgacon, Synaps and certain classic film products • Recurring EBIT at 1.2 million Euro • Business highlights • Microfilm: • Long-term exclusive supply agree
Slide 18: Q&A
Q&A AGFA <>